Matthew Zirwas, MD: What’s New in Systemics in Atopic Dermatitis

Dr. Zirwas reviews new advancements in systemics for atopic dermatitis including JAK inhibitors and the current black box warnings for these treatments.

Neal Bhatia, MD: New Therapies in the Field of Dermatology

Dr. Bhatia reviews an array of new therapies discussed during his New Drugs and Therapies presentation at Maui Derm 2023.

Neal Bhatia, MD: New Opportunities for JAK Inhibitors

Dr. Bhatia gives an overview of the utilization of JAK inhibitors in diseases such as hidradenitis suppurativa, vitiligo, alopecia areata, psoriasis, and atopic dermatitis.

Neal Bhatia, MD: Ritlecitinib as an Emerging Therapy for Alopecia Areata

Dr. Bhatia details the recent approval of Ritlecitinib which is launching soon for the treatment of alopecia areata.

Linda Stein Gold, MD: Exploring the Impact of Novel TYK2 Inhibitors in Plaque Psoriasis​

Dr. Stein Gold discusses her presentation at Maui Derm 2023 which focused on new TYK2 inhibitors for the treatment of plaque psoriasis, along with other exciting drugs on the horizon.